Clinical trial
Complementary Effects of New Diabetes Medications on Adrenal Function and Intestinal Microbiota
NCT04151849 is registered in ClinicalTrials.gov with University of Tartu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Complementary Effects of New Diabetes Medications on Adrenal Function and Intestinal Microbiota
- Lead sponsor
- University of Tartu
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 7, 2019
- Completion date
- January 23, 2023
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes